疏血通联合盐酸倍他司汀治疗脑血栓椎-基底动脉系统供血不足的疗效研究

Study on the Efficiency of Shuxuetong Combined with Betahistine Hydrochloride for the Treatment of Vertebrobasilar Insufficiency in Patients with Cerebral Thrombus

目的研究疏血通联合盐酸倍他司汀治疗脑血栓椎-基底动脉系统供血不足的效果。方法选取我院2014年4月至2016年8月收治的56例脑血栓椎-基底动脉供血不足的患者作为研究对象,随机分为两组各28例。观察组采用疏血通联合盐酸倍他司汀治疗,对照组单用盐酸倍他司汀治疗,治疗周期为14天。治疗结束后比较两组患者的治疗效果及不良反应发生情况。结果观察组的治疗总有效率为96.4%,显著高于对照组的75.0%,差异有统计学意义(P<0.05)。两组均无明显不良反应发生。结论采用疏血通联合盐酸倍他司汀治疗脑血栓椎-基底动脉系统供血不足疗效确切,值得在临床中推广。

Objective To study the therapeutic effect of Shuxuetong combined with betahistine hydrochloride for the treatment of vertebrobasilar insufficiency in patients with cerebral thrombus. Methods 56 cases of patients with cerebral thrombosis complicated with vertebrobasilar insufficiency admitted to our hospital from April 2014 to August 2016 were selected and randomly divided into two groups, with 28 cases in each group. The control group was treated with betahistine hydrochloride only, while the observation group was treated with Shuxuetong combined with betahistine hydrochloride. Both groups were treated for 14 days. The therapeutic effect and incidences of adverse reactions of two groups were compared. Results The total effective rate of treatment of observation group was 96.4%, significantly higher than 75.0% of control group （P 〈0.05）. No obvious adverse reaction was found in both groups. Conclusions Shuxuetong combined with betahistine hydrochloride has significant efficacy for the treatment ofvertebrobasilar insufficiency in patients with cerebral thrombus.